PENTAX Medical Appoints Dr. Hudson Garrett, Global Chief Clinical Officer
PENTAX Medical, a division of HOYA Corporation, announced the appointment of Dr. Hudson Garrett to the position of Global Chief Clinical Officer. In this executive role, Hudson Garrett is responsible for leading all PENTAX Medical clinical related activities globally.
PENTAX Medical has decided to establish this role to accelerate its focus on delivering clinically relevant products to improve quality and standard of patient care. Dr. Garrett’s expertise and experiences in infection control in various medical institutions will enforce its commitment to minimize risk of infection and cross contamination. It will also further develop the scientific community by investing in professional education to raise the bar of patient care.
“Hudson joins PENTAX Medical with valuable expertise gained from various segments of the medical field on the vender and provider side”, said David Woods, Global CMO of PENTAX Medical, HOYA Group. “He has the credentials and expertise to oversee PENTAX Medical’s clinical activities by working with our customers, industry partners and internal team members to develop and deliver high quality products cost effectively with attention to provider and patient satisfaction.”
“I am committed to make the best use of my clinical background in infection prevention, control and clinical affairs to position PENTAX Medical as a thought leader in medical device hygiene, evidence-based clinical education, and clinical research”, Dr. Garrett says. “I am committed to ensuring we clearly demonstrate the PENTAX Medical ethos of offering clinically advanced evidence-based products.”
Dr. Garrett holds a Bachelor of Science degree in biology/chemistry and nursing, dual masters in nursing and public health, a post-masters certificate as a family nurse practitioner, a post-masters certificate in infection prevention and control, and a PhD in healthcare administration and policy. He is a graduate of the Johns Hopkins Fellowship in Infection Control and Hospital Epidemiology, and was honored as a Who’s Who in Infection Control Today Magazine in 2013.
About PENTAX Medical
PENTAX Medical is a division of Hoya Group. Its mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY. Through leading edge R&D and manufacturing, PENTAX Medical provides endoscopic imaging devices and solutions to the global medical community. Headquartered in Japan, PENTAX Medical has a worldwide focus and presence with R&D, regional sales, service, and in-country facilities around the globe. For more information, please visit: www.pentaxmedical.com .
GM, Corporate Communications & Product Branding
Mobile phone: +81-80-4794-5842
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
NY-GTIS-PARTNERS20.9.2017 15:34 | pressemeddelelse
GTIS Partners Clinches Sustainability Performance Top Honors for Third Year Running
PA-MEET-GROUP20.9.2017 14:33 | pressemeddelelse
The Meet Group to Acquire LOVOO
ARTHUR-D.-LITTLE20.9.2017 13:02 | pressemeddelelse
Arthur D. Little Urges Network Operators to Prepare for Next-Generation Internet of the GigaWorld
LINTEC-CORPORATION20.9.2017 12:47 | pressemeddelelse
LINTEC Announces Four New Adhesive Materials for Labels
QUINTIQ20.9.2017 12:07 | pressemeddelelse
EGS Invests in Artificial Intelligence from Quintiq
FL-SES20.9.2017 11:05 | pressemeddelelse
EchoStar 105/SES-11 Shipped from Toulouse to the Cape for SpaceX Launch
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum